The Ikaros gene undergoes bi-allelic changes at a high frequency in γ γ γ γ-ray-induced mouse thymic 
The Ikaros gene encodes multiple protein isoforms with zinc finger domains that play an important role in the development of lymphocytes and other hematopoietic cell types. [1] [2] [3] [4] Studies of Ikaros KO mice suggest that Ikaros participates in proliferation of thymocytes and in an oncogenic process. 5) Another gene related to Ikaros was identified by the use of degenerate primers complementary to sequences encoding the carboxy-terminal zinc finger of Ikaros. This gene, designated as Aiolos, exhibits considerable homology to Ikaros and its expression is restricted to the lymphoid lineage, like that of Ikaros. 6) Helios is a third member of the Ikaros gene family and is expressed primarily in T-cells. 7, 8) All members of the Ikaros family consist of four N-terminal DNA-binding zinc fingers, a conserved bipartite activation domain and two C-terminal zinc fingers, and bind to similar DNA sequences. They interact physically with each other through the carboxy-terminal zinc fingers, as detected by co-immunoprecipitation and also by nuclear staining with antibodies. [5] [6] [7] [8] We have previously demonstrated that Ikaros functions as a tumor suppressor gene in the development of γ-rayinduced mouse thymic lymphomas. 9) About 20% of the lymphomas examined underwent bi-allelic DNA alterations of the Ikaros gene. As described above, Helios and Aiolos have sequence homologies to Ikaros and show protein-protein interactions, and therefore these two genes might also be involved in lymphoma development. This prompted us to perform genetic mapping and to examine allelic loss in the γ-ray-induced mouse thymic lymphomas. In this paper, we show the chromosomal location of Helios and Aiolos and demonstrate that neither gene shows frequent allelic loss or bi-allelic changes in the thymic lymphomas.
MATERIALS AND METHODS
Mice and lymphomas MSM is an inbred strain derived from Japanese wild mice, Mus musculus molossinus. 10) The details of lymphoma induction were described previously. 11) In brief, the parental p53-deficient mouse was originally produced by introduction of a neo-gene fragment into the p53 gene locus in the ES cells that had been derived from F 1 mouse between C57BL/6(B6) and CBA strains. 12) We have developed a congenic MSM mouse carrying a p53-deficient allele by backcrossing this p53-deficient mouse to MSM mice for 13 generations. The male mice (N10 to N13 generation) with the genotype of p53(KO/ +) were mated with BALB/c female mice. The mice were then subjected to γ-ray irradiation, 2.5 Gy four times at weekly intervals, starting at the age of 4 weeks. Development of thymic lymphoma was diagnosed on the basis of observation of labored breathing. Polymerase chain reaction (PCR) analysis Isolation of genomic DNA from lymphomas and brain was carried out by using standard protocols. PCR and separation of PCR products by gel electrophoresis were performed as described previously. 9, 11) Primer sequences Three primer sequences used for the Helios gene were as follows: Helios exon 7-1, 5′-ATAAGCTCAGCTTATT-CTCAGG and 5′-ATGTCGC-CATCCGTGGGAAG for detection of a polymorphism and for mutation and homozygous deletion analyses; Helios exon 7-2, 5′-GTGTTCAGTTAACTTCTCATACC and 5′-AGAAGTGGGGCCATCCATGT for mutation analysis; Helios exon 4, 5′-GAACCTAGGAAATTGTCT-GTGG and 5′-CTCTCTGCCAAAGCTACATGG for homozygous deletion analysis and mutation analysis. Two primer sets for Aiolos were as follows: Aiolos exon 7-1, 5′-CGGATGATGGACCAAGCCAT and 5′-AGCACAG-AGCCATGTTGAAG for detection of a polymorphism; Aiolos exon 7-2, 5′-CGGATGATGGACCAAGCCAT and CCTCCTTCAGAAGA-GGCATCGC for allelic loss analysis. Primers for the catenin gene were as described previously. 13) Microsatellite markers were synthesized according to reported sequences. 14) Isolation of BACs BAC clones were isolated by PCR screening of a library that was purchased from Research Genetics, Inc. (Huntsville, AL). Typing of p53 p53 genotyping was carried out as described previously. 9, 15) One primer (F1-53) located in exon 1 of the p53 gene, a second primer (R1-53) in a region 5′ to exon 3, and the remaining one (F2-neo) in the neo gene insert. F1-53 and R1-53 amplified a region of the p53 gene to produce a fragment of 500 bp. F2-neo and R1-53 gave an 800 bp fragment comprising a part of the neo and p53 gene. Therefore, the 500 bp band and the 800 bp band represent the normal allele and the mutant allele, respectively. F 1 mice of the p53(+ / +) genotype exhibited two distinct p53 alleles originating from different mouse subspecies, Mus m. molossinus and Mus m. domesticus. A primer set amplifying a polymorphic region upstream from the transcription start site was synthesized and used for allelic loss analysis of those lymphomas.
RESULTS
Genetic polymorphisms were searched to map Helios and Aiolos genes on the mouse chromosome. Since only the cDNA sequence was available for either gene, we sequenced genomic DNA and BAC clones corresponding to Ikaros exon 7 by aligning their cDNA sequences with cDNA and genomic sequences of Ikaros. As for Helios, a base-substitution between BALB/c and MSM genomes, which creates an AatII restriction enzyme cleavage site, was found and accordingly a set of primers was designed to detect the polymorphism. Gel electrophoresis of AatII digests of PCR products with the primers gave an undigested DNA fragment for BALB/c and two digested fragments for MSM (see Fig. 2 ). The difference was used for genotyping of 131 intersubspecific backcross mice that were obtained by mating (C57BL/6×MSM)F 1 females to MSM males. Likewise, an AccII recognition site polymorphism was found in Aiolos by sequence analysis. A set of primers was synthesized accordingly and used for genotyping. Fig. 1 shows the mapping results of the two genes. The Helios gene is located between markers D1Mit531 and D1Mit19 on chromosome 1, and the Aiolos gene is between D11Mit222 and D11Mit332 on chromosome 11.
Allelic loss analysis of Helios was carried out using the primers used for the Helios mapping and also two markers flanking Helios. Fig. 2A shows gel electrophoretic patterns of AatII digests of the Helios PCR products and the PCR products of D1Mit531 and D1Mit19. Allelic differences were clearly seen. The frequency of allelic loss was 3.9% (7/180) at the D1Mit531 locus, 4.4% (8/180) at the Helios locus and 3.9% (7/180) at the D1Mit19 locus; thus the loss frequency at Helios was higher than those at the other two loci. Fig. 3A shows a compilation of allelic losses at the three loci in individual lymphomas which allows us to classify the lymphomas into four types: type A, lymphomas retaining both alleles of all three loci; type B, lymphomas lacking one chromosomal region of MSM that covers all three loci; type C, lymphomas showing allelic losses at the centromeric two loci but retaining both alleles of the telomeric locus; type D, lymphomas retaining both alleles of the centromeric locus but showing allelic losses at the telomeric two loci. There were two lymphomas, one being a type C lymphoma and the other type D, which might suggest the involvement of Helios in lymphomagenesis.
Likewise, allelic loss analysis was done for Aiolos in a similar manner. Fig. 2B shows examples of AccII digests of PCR products, together with PCR products of D11Mit222 and D11Mit332, and Fig. 3B summarizes the results of compilation. There was a lymphoma of type E which exhibited allelic loss only at the Aiolos locus. The frequency of allelic loss was 19% (34/180) at the Aiolos locus, although the loss had a strong preference for the BALB/c allele (see below).
Inactivation of the p53 gene in lymphomas may affect the allelic loss frequency of Helios and Aiolos loci because p53 functions to maintain the genome integrity. [16] [17] [18] [19] Besides, the p53 and Aiolos genes reside on the same chromosome 11 and hence single allelic loss events at a Two triangles of C and M represent both BALB/c and MSM alleles retained, and one triangle represents one allele lost. Combination of the status of the alleles allows lymphomas to be divided into four types at both loci: type A, lymphomas retaining both alleles of all three loci; type B, lymphomas lacking one chromosomal region of BALB/c or MSM that covers all three loci; type C, lymphomas showing allelic losses at the centromeric two loci but retaining both alleles of the telomeric locus; type D, lymphomas retaining both alleles of the centromeric locus but showing allelic losses at the telomeric loci; type E, lymphomas exhibiting allelic loss only at the Aiolos locus. The number of lymphomas of each type is listed at the bottom.
site of the chromosome may well involve both loci, which can increase the allelic loss frequency of Aiolos. Therefore, the relation between allelic losses of the Helios or Aiolos locus and the p53 locus was investigated. p53 genotyping of lymphomas and the host mice was performed using three sets of primers (see "Materials and Methods"). The typing allowed us to classify 180 lymphomas into four p53 genotypes: [1] (+ / +), both wild-type alleles retained; [2] (+ / −), one of the two wild-type alleles lost; [3] (KO/ +), the KO allele and the wild-type allele retained; [4] (KO/ −), the KO allele retained but the wild-type allele lost. The numbers of lymphomas in these four classes were 75, 3, 19, and 83, respectively. Table I summarizes the status of the Helios and Aiolos alleles in lymphomas of the four different p53 genotypes. It is noteworthy that at either gene locus no allelic loss was found in lymphomas that were induced in p53 wildtype mice. The eight lymphomas showing allelic loss at the Helios locus were all p53(KO/ −). This may reflect cooperativity between losses of Helios and p53 or the consequence of genomic instability conferred by the p53 loss. Similarly, 33 of the 34 lymphomas showing allelic loss at the Aiolos locus were p53(KO/ −). The allelic loss had a strong preference for the allele on the BALB/c chromosome that carried a wild-type p53 allele; all of the losses were of the BALB/c allele. This suggests that almost all of the allelic losses found in Aiolos are only the consequence of the wild-type p53 allele being lost.
Allelic loss frequency was very low at either of the Helios and Aiolos loci relative to that of Ikaros. No notable concordance of losses among the three genes was observed (data not shown). This suggests little involvement of the two genes in the thymic lymphoma development. However, further analyses were done to examine biallelic changes in the two genes. In our previous study of Ikaros, we found nine lymphomas with homozygous deletion and six mutations in the zinc finger domain regions. Therefore, analysis of homozygous deletion and mutations was done in a similar manner. For the assay of homozygous deletion of Helios, two pairs of primers on the putative exons 4 and 7 and a primer set for the catenin gene as a positive control were synthesized and used for the eight lymphomas that showed allelic loss. No pattern indicative of homozygous deletion was detected in these samples (data not shown). For mutation analysis of the putative exons 4 and 7, intron-specific primers and primers on the exons were used. We failed to find any mutation in the region. Although preliminary, these results did not provide evidence for involvement of Helios in the development of thymic lymphoma. As for the Aiolos gene, similar studies were carried out for the 34 lymphomas with allelic loss. No result indicating bi-allelic DNA alteration was obtained (data not shown).
DISCUSSION
We previously showed that the Ikaros gene undergoes bi-allelic changes at a high frequency in γ-ray-induced mouse thymic lymphomas. 9) In this paper we have tested whether or not Helios and Aiolos, two other members of the Ikaros gene family, are also involved in lymphomagenesis. In contrast to Ikaros, no result was obtained which suggests any obvious contribution of Helios or Aiolos to the development of mouse thymic lymphomas.
The Ikaros family of proteins, Ikaros, Helios and Aiolos, are characterized by the presence of four N-terminal DNA-binding zinc fingers, a conserved bipartite activation domain, and two C-terminal zinc fingers. 20) They can activate transcription of reporter genes driven by the Ikaros consensus binding site, 5′-GGGAA-3′. Gene disruption 5, 21) One carries a deletion of the Ikaros DNA-binding domain that displays dominant negative effects on transcription through interaction at the Cterminal domain with proteins of the Ikaros family (Ikaros-DN type), and the other harbors a deletion of the last translated C-terminal exon (Ikaros-C type). Interestingly, heterozygotes of the Ikaros-DN mouse strain, but not the Ikaros-C strain, exhibit defects in the T lineage, which lead to an abnormal accumulation of CD4/CD8 double-positive thymocytes and ultimately result in T cell leukemia and lymphomas. Ikaros controls T cell proliferative responses and probably functions as a growth suppressor, and hence loss of the gene function may confer a growth advantage upon these cells which fosters the development of a tumor. 5) On the other hand, mice homozygous for an Aiolos-null mutation exhibit a much less severe lymphopoietic defect than Ikaros KO homozygotes do, and the development of B cell lymphomas is frequently seen among aging mutants. 22) The results of gene disruption experiments suggest the involvement of Ikaros and possibly Aiolos in the development of T cell lymphomas of the mouse. Our previous analysis provided further genetic evidence implicating Ikaros in the development of lymphomas in Ikaros wild-type mice by showing bi-allelic changes in about 20% of the γ-ray-induced mouse thymic lymphomas. 9) Immunoprecipitation experiments showed that proteinprotein interaction allows Ikaros proteins to dimerize with Helios or Aiolos proteins, as well as themselves. The Cterminal zinc fingers provide a site for these interactions. [6] [7] [8] Recent studies of subnuclear localization in B and T cells provide direct evidence of the protein interactions. The Ikaros-Helios complexes localize to the centromeric heterochromatin in T cells, 7, 8) and Aiolos dimers with Ikaros proteins localize to the same discrete regions within the nucleus of transfected NIH3T3 cells. 6) These complexes in the nucleus are probably important for transcriptional regulation. 7, 8, 23) Ikaros isoforms are expressed in most cells of the hematopoietic lineages, including multipotent stem cells. [1] [2] [3] [4] Helios shows a restricted expression pattern and is transcribed in a subset of cells of the T cell lineage. 7, 8) On the other hand, Aiolos is expressed in most of the cell types that express Ikaros, but a high expression is seen in mature B cells. 6, 21) These results suggest functional cooperativity of the three proteins and that the cooperativity may be cell type-specific.
As described above, Ikaros is a tumor suppressor gene and Helios and Aiolos, other members of the Ikaros gene family, directly interact with Ikaros and form functional units in cell nuclei. This raised the possibility that Helios and/or Aiolos may also function as tumor suppressor genes in the development of thymic lymphomas. However, no evidence for that was obtained in this study of Helios and Aiolos.
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